PROCTER & GAMBLE HEALTH
|
PROCTER & GAMBLE HEALTH Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Jun2024 | Jun2023 | Jun2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 196.93 | 141.21 | 121.07 | 138.23 | 115.98 |
| CEPS(Rs) | 211.14 | 151.27 | 137.58 | 155.16 | 132.29 |
| DPS(Rs) | 205.00 | 125.00 | 260.00 | 95.00 | 52.50 |
| Book NAV/Share(Rs) | 312.92 | 320.52 | 319.10 | 447.62 | 366.99 |
| Tax Rate(%) | 27.33 | 24.78 | 26.47 | 26.97 | 24.02 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 28.90 | 30.94 | 24.30 | 24.44 | 22.73 |
| EBIT Margin(%) | 28.74 | 30.32 | 21.76 | 23.71 | 21.55 |
| Pre Tax Margin(%) | 28.70 | 30.28 | 21.71 | 23.66 | 21.51 |
| PAT Margin (%) | 20.86 | 22.78 | 15.96 | 17.28 | 16.35 |
| Cash Profit Margin (%) | 22.36 | 24.40 | 18.14 | 19.39 | 18.64 |
| Performance Ratios | |||||
| ROA(%) | 41.65 | 30.85 | 13.43 | 11.00 | 9.83 |
| ROE(%) | 62.18 | 44.15 | 31.58 | 33.94 | 29.41 |
| ROCE(%) | 84.86 | 58.05 | 42.52 | 46.07 | 38.45 |
| Asset Turnover(x) | 2.00 | 1.35 | 0.84 | 0.64 | 0.60 |
| Sales/Fixed Asset(x) | 6.92 | 4.62 | 5.18 | 5.27 | 5.17 |
| Working Capital/Sales(x) | 5.20 | 3.31 | 4.12 | 2.70 | 3.13 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.14 | 0.22 | 0.19 | 0.19 | 0.19 |
| Receivable days | 36.06 | 40.92 | 29.14 | 27.36 | 22.20 |
| Inventory Days | 28.65 | 38.75 | 35.37 | 34.37 | 36.19 |
| Payable days | 181.85 | 235.41 | 223.07 | 206.35 | 188.51 |
| Valuation Parameters | |||||
| PER(x) | 24.36 | 36.42 | 41.71 | 37.97 | 36.10 |
| PCE(x) | 22.72 | 34.00 | 36.71 | 33.83 | 31.65 |
| Price/Book(x) | 15.33 | 16.04 | 15.83 | 11.73 | 11.41 |
| Yield(%) | 4.27 | 2.43 | 5.15 | 1.81 | 1.25 |
| EV/Net Sales(x) | 5.53 | 8.94 | 7.07 | 6.73 | 5.95 |
| EV/Core EBITDA(x) | 16.41 | 25.39 | 25.30 | 24.12 | 23.59 |
| EV/EBIT(x) | 17.27 | 26.75 | 29.70 | 26.27 | 26.11 |
| EV/CE(x) | 14.83 | 15.55 | 15.12 | 11.02 | 10.75 |
| M Cap / Sales | 5.66 | 9.14 | 7.28 | 7.09 | 6.24 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 50.72 | -18.86 | -6.37 | 10.34 | 10.48 |
| Core EBITDA Growth(%) | 44.19 | 2.21 | -6.25 | 22.15 | 6.34 |
| EBIT Growth(%) | 44.34 | 13.87 | -12.99 | 24.11 | 8.42 |
| PAT Growth(%) | 39.46 | 16.63 | -12.42 | 19.19 | 8.89 |
| EPS Growth(%) | 39.46 | 16.63 | -12.42 | 19.19 | 8.89 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 2.18 | 2.44 | 2.39 | 1.72 | 1.62 |
| Quick Ratio(x) | 1.65 | 1.94 | 1.90 | 1.53 | 1.43 |
| Interest Cover(x) | 818.93 | 725.70 | 380.61 | 409.05 | 604.26 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of PROCTER & GAMBLE HEALTH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PROCTER & GAMBLE HEALTH | ₹8,973.3 Cr | -1% | -5.7% | -13.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
PROCTER & GAMBLE HEALTH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PROCTER & GAMBLE HEALTH | -1% |
-5.7% |
-13.4% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses
